| scholarly article | Q13442814 |
| P2093 | author name string | K Takahashi | |
| S Miyake | |||
| S Hashimoto | |||
| T Kondo | |||
| T Yamamura | |||
| K Terao | |||
| M Hatakenaka | |||
| P2860 | cites work | Functional diversity of helper T lymphocytes | Q29619415 |
| Biology of natural killer cells | Q29619728 | ||
| New diagnostic criteria for multiple sclerosis: guidelines for research protocols | Q34271601 | ||
| Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein | Q34293468 | ||
| Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice | Q34411828 | ||
| GATA-3 induces T helper cell type 2 (Th2) cytokine expression and chromatin remodeling in committed Th1 cells | Q35834668 | ||
| Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cells | Q36380304 | ||
| Autopathogenic T helper cell type 1 (Th1) and protective Th2 clones differ in their recognition of the autoantigenic peptide of myelin proteolipid protein | Q36380584 | ||
| Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells | Q36380889 | ||
| Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis | Q36401257 | ||
| Lymphocyte responses and cytokines | Q40620203 | ||
| Induction of resistance to active experimental allergic encephalomyelitis by myelin basic protein-specific Th2 cell lines generated in the presence of glucocorticoids and IL-4. | Q40890535 | ||
| IL-4, IL-10, IL-13, and TGF-beta from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis | Q40892672 | ||
| IL-13 production by NK cells: IL-13-producing NK and T cells are present in vivo in the absence of IFN-gamma. | Q40981505 | ||
| Differential responsiveness of the IL-5 and IL-4 genes to transcription factor GATA-3. | Q41001778 | ||
| Production of IL-10 by human natural killer cells stimulated with IL-2 and/or IL-12. | Q41057500 | ||
| Production of IL-5 by human NK cells and regulation of IL-5 secretion by IL-4, IL-10, and IL-12. | Q41345577 | ||
| Mouse CD1-specific NK1 T cells: development, specificity, and function | Q41464349 | ||
| IL-5 production by NK cells contributes to eosinophil infiltration in a mouse model of allergic inflammation. | Q43714564 | ||
| Differentiation of human NK cells into NK1 and NK2 subsets. | Q52036591 | ||
| CD95 expression and CD95-mediated apoptosis of T cells in multiple sclerosis. No differences from normal individuals and no relation to HLA-DR2. | Q57623671 | ||
| Increased serum levels of soluble CD95 (APO-1/Fas) in relapsing-remitting multiple sclerosis | Q57623673 | ||
| Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells | Q59387569 | ||
| Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells | Q73098737 | ||
| Differential expression of NK T cell V alpha 24J alpha Q invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy | Q73644565 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | multiple sclerosis | Q8277 |
| bias | Q742736 | ||
| P304 | page(s) | R23-9 | |
| P577 | publication date | 2001-03-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Natural killer type 2 bias in remission of multiple sclerosis | |
| P478 | volume | 107 |
| Q33412876 | Alterations in immune cell subsets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP). |
| Q37085371 | Altered gene expression and function of peripheral blood natural killer cells in children with autism |
| Q39650071 | Analysis of circulating T gamma/delta lymphocytes and CD16/56 cell populations in children and adolescents with Graves' disease |
| Q33664396 | Analysis of the cellular mechanism underlying inhibition of EAE after treatment with anti-NKG2A F(ab')2 |
| Q82938471 | Anticipated benefits and surprising effects of daclizumab in multiple sclerosis |
| Q37128253 | Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS. |
| Q37128257 | Antiviral NK cell responses in HIV infection: II. viral strategies for evasion and lessons for immunotherapy and vaccination |
| Q81609274 | Different natural killer (NK) receptor expression and immunoglobulin E (IgE) regulation by NK1 and NK2 cells |
| Q44576446 | Divergence in NK cell and cyclic AMP regulation of T cell CD40L expression in asthmatic subjects |
| Q37778622 | Emerging concepts in autoimmune encephalomyelitis beyond the CD4/TH1 paradigm |
| Q80551920 | Expansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta |
| Q27022458 | Functional Significance of CD57 Expression on Human NK Cells and Relevance to Disease |
| Q42492762 | Identical twins discordant for type 1 diabetes show a different pattern of in vitro CD56+ cell activation |
| Q38156767 | Initial immunopathogenesis of multiple sclerosis: innate immune response. |
| Q60920839 | Innate Immunity Cells and the Neurovascular Unit |
| Q59349868 | KIR2DL4-HLAG interaction at human NK cell-oligodendrocyte interfaces regulates IFN-γ-mediated effects |
| Q52613089 | Mucosal-associated invariant T cells regulate Th1 response in multiple sclerosis. |
| Q36385464 | Multiple sclerosis and virus induced immune responses: autoimmunity can be primed by molecular mimicry and augmented by bystander activation |
| Q37770795 | Multiple sclerosis: risk factors, prodromes, and potential causal pathways |
| Q34541173 | NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndrome |
| Q37552129 | NK cell autoreactivity and autoimmune diseases. |
| Q53080352 | Natural killer (NK) cell deficit in coronary artery disease: no aberrations in phenotype but sustained reduction of NK cells is associated with low-grade inflammation. |
| Q24793284 | Natural killer cells and autoimmunity |
| Q37124504 | Natural killer cells and their receptors in multiple sclerosis |
| Q37779313 | Natural killer cells as indispensable players and therapeutic targets in autoimmunity |
| Q34027448 | Natural killer cells control a T-helper 1 response in patients with Behçet's disease |
| Q37690952 | Natural killer cells in human autoimmune disorders |
| Q37754682 | Natural killer cells: versatile roles in autoimmune and infectious diseases |
| Q93052142 | Non-Genetically Improving the Natural Cytotoxicity of Natural Killer (NK) Cells |
| Q35134649 | Pathogenesis of endometriosis: natural immunity dysfunction or autoimmune disease? |
| Q50982454 | Pilot Study of Natural Killer Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis. |
| Q44008838 | Postnatal maternal deprivation aggravates experimental autoimmune encephalomyelitis in adult Lewis rats: reversal by chronic imipramine treatment |
| Q36602589 | Reciprocal regulation between natural killer cells and autoreactive T cells |
| Q39032832 | Regulatory Functions of Natural Killer Cells in Multiple Sclerosis. |
| Q35817615 | Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis. |
| Q33787624 | Role of the innate immune system in the pathogenesis of multiple sclerosis |
| Q48854619 | Role of vitamin D in the physiopathology of neurodegenerative diseases |
| Q43228864 | Season of birth and not vitamin D receptor promoter polymorphisms is a risk factor for multiple sclerosis. |
| Q36394834 | The immunogenetics of multiple sclerosis: A comprehensive review |
| Q46094020 | The immunogenetics of neurological disease. |
| Q24597958 | The innate immune system in demyelinating disease |
| Q34613914 | The natural killer cell -- friend or foe in autoimmune disease? |
| Q35855834 | The role of NK cells and NK cell receptors in autoimmune disease |
| Q36407758 | The role of natural killer cells in curbing neuroinflammation |
| Q35610755 | Tolerogen-induced interferon-producing killer dendritic cells (IKDCs) protect against EAE. |
Search more.